Which dosing approach is recommended for loading dosing of a lipophilic drug in obese patients?

• A. Use total body weight for loading dose.
• B. Use ideal body weight for loading dose.
• C. Use lean body mass or adjusted body weight for loading dose.
• D. Dose should not be adjusted for obesity.

Answer: (C)

The main idea is that the initial amount of drug needed to reach a target plasma concentration (the loading dose) depends on how widely the drug distributes in the body, described by the volume of distribution. For lipophilic drugs, distribution into fat tissue increases with obesity, so the overall Vd grows as body fat rises. However, the factors that govern how quickly and fully the drug clears from the body are more closely tied to lean tissues and organ mass. To strike a balance and achieve the desired plasma level without overdosing, clinicians estimate the loading dose using body weight measures that reflect lean tissue and metabolic capacity—namely lean body mass or adjusted body weight—rather than total body weight alone or ideal body weight.

Using total body weight would overestimate the needed dose because it attributes all extra weight (mostly adipose) to distribution and clearance, risking excessive initial concentrations. Using ideal body weight tends to underestimate Vd for lipophilic drugs in obese patients, risking underdosing. Adjusted body weight or lean body mass provides a more accurate reflection of the portion of body mass that contributes to distribution into tissues and to metabolic handling, leading to a more appropriate loading dose.

So, for loading dosing of a lipophilic drug in obese patients, lean body mass or adjusted body weight is the best approach.